Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Samcyprone by Phio Pharmaceuticals for Alopecia Areata: Likelihood of Approval
Samcyprone is under clinical development by Phio Pharmaceuticals and currently in Phase III for Alopecia Areata. According to GlobalData, Phase...